Choose Language
Select a language for news translation.
Written by John Bromels for The Motley Fool -> Shares of Danish drugmaker Novo Nordisk fell nearly 10% today. The drop came after an experimental cardiovascula…
In trading on Tuesday, shares of Novo-Nordisk AS (Symbol: NVO) crossed below their 200 day moving average of $106.41, changing hands as low as $106.29 per shar…
Written by Matthew Benjamin for The Motley Fool -> Both companies are giants in diabetes and obesity treatments. Lately, Eli Lilly has moved ahead in the obe…
Novo Nordisk A/S (NYSE: NVO ) was at the center of media coverage as it sued rival weight loss drug manufacturer Eli Lilly on Tuesday. The firm claimed that Li…
Written by James Brumley for The Motley Fool -> Novo Nordisk has run into unexpected headwinds lately, but all these challenges (and then some) may already be …




















